Publishing research using ab138501? Please let us know so that we can cite the reference in this datasheet.

ab138501 has been referenced in 24 publications.

  • Abbineni PS  et al. Identification of ß-synuclein on secretory granules in chromaffin cells and the effects of a- and ß-synuclein on post-fusion BDNF discharge and fusion pore expansion. Neurosci Lett 699:134-139 (2019). PubMed: 30711526
  • Huang CC  et al. Soluble a-synuclein facilitates priming and fusion by releasing Ca2+ from the thapsigargin-sensitive Ca2+ pool in PC12 cells. J Cell Sci 131:N/A (2018). PubMed: 30404828
  • Cao Z  et al. a-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease. Neurosci Lett 696:114-120 (2018). PubMed: 30579996
  • Tatulli G  et al. Intermittent Fasting Applied in Combination with Rotenone Treatment Exacerbates Dopamine Neurons Degeneration in Mice. Front Cell Neurosci 12:4 (2018). PubMed: 29387000
  • Olesen MN  et al. CD4 T cells react to local increase of a-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology. Heliyon 4:e00513 (2018). PubMed: 29560431
  • Fernández-Espejo E & Bis-Humbert C Excess amounts of 3-iodo-l-tyrosine induce Parkinson-like features in experimental approaches of Parkinsonism. Neurotoxicology 67:178-189 (2018). PubMed: 29885340
  • Rodriguez-Perez AI  et al. Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death. Neurotherapeutics N/A:N/A (2018). PubMed: 29987762
  • Ju C  et al. Neuroprotective effect of chondroitin sulfate on SH-SY5Y cells overexpressing wild-type or A53T mutant a-synuclein. Mol Med Rep 16:8721-8728 (2017). WB . PubMed: 28990084
  • Liu X  et al. Astragaloside IV attenuates the H2O2-induced apoptosis of neuronal cells by inhibiting a-synuclein expression via the p38 MAPK pathway. Int J Mol Med 40:1772-1780 (2017). PubMed: 29039448
  • Doucet M  et al. Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles. PLoS One 12:e0181844 (2017). PubMed: 28797124
  • Plotegher N  et al. DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function. Sci Rep 7:40699 (2017). WB ; Human . PubMed: 28084443
  • de Oliveira RM  et al. The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol 15:e2000374 (2017). ICC/IF ; Mouse . PubMed: 28257421
  • Chiba-Falek O Structural variants in SNCA gene and the implication to synucleinopathies. Curr Opin Genet Dev 44:110-116 (2017). ICC/IF . PubMed: 28319736
  • Brahic M  et al. Axonal transport and secretion of fibrillar forms of a-synuclein, Aß42 peptide and HTTExon 1. Acta Neuropathol 131:539-48 (2016). ICC/IF . PubMed: 26820848
  • Maekawa T  et al. Leucine-rich repeat kinase 2 (LRRK2) regulates a-synuclein clearance in microglia. BMC Neurosci 17:77 (2016). Mouse . PubMed: 27903237
  • Rasmussen NB  et al. 5-HT2A Receptor Binding in the Frontal Cortex of Parkinson's Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study. Parkinsons Dis 2016:3682936 (2016). WB ; Human . PubMed: 27579212
  • Ludtmann MH  et al. Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase. J Neurosci 36:10510-10521 (2016). WB, ICC/IF ; Mouse . PubMed: 27733604
  • Brudek T  et al. Altered a-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains. J Neurochem 136:172-85 (2016). WB . PubMed: 26465922
  • Gray MT  et al. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord 29:991-8 (2014). IF ; Human . PubMed: 24352892
  • Woulfe JM  et al. Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease. Parkinsonism Relat Disord 20:685-94 (2014). PubMed: 24726430
  • Volpicelli-Daley LA  et al. Addition of exogenous a-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous a-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc 9:2135-46 (2014). PubMed: 25122523
  • Janezic S  et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci U S A 110:E4016-25 (2013). WB ; Mouse . PubMed: 24082145
  • Mollenhauer B  et al. a-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system. J Neural Transm 119:739-46 (2012). IHC-P ; Mouse . PubMed: 22426833
  • Mollenhauer B  et al. Total CSF a-synuclein is lower in de novo Parkinson patients than in healthy subjects. Neurosci Lett : (2012). ELISA ; Human . PubMed: 23149132

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up